HYQVIA- immune globulin infusion 10% (human) with recombinant human hyaluronidase 
Bamboo US BidCo LLC

----------

These highlights do not include all the information needed to use HYQVIA safely and effectively. See full prescribing information for HYQVIA.

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration
Initial U.S. Approval: 2014

PRINCIPAL DISPLAY PANEL - 2.5 g/25 mL Vial Label

Immune Globulin Infusion 10% (Human)

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421
U.S. License No. 1898

Infuse 2nd

2.5 g/
25 mL

IG

LE-07-54397

Takeda

PRINCIPAL DISPLAY PANEL - 2.5 g/25 mL Vial Label

PRINCIPAL DISPLAY PANEL - 1.25 mL Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421

Infuse 1st

HY

1.25 mL
160 units per mL

Takeda

PRINCIPAL DISPLAY PANEL - 1.25 mL Vial Label

PRINCIPAL DISPLAY PANEL - 2.5 g/25 mL Kit Carton

Immune Globulin Infusion 10% (Human)

with Recombinant Human Hyaluronidase
HYQVIA

For Subcutaneous Administration Only.

Single-use dual vial unit

Directions for use:
Read the enclosed Package Insert.

No preservative

Rx Only

2.5 g/
25 mL

Takeda

PRINCIPAL DISPLAY PANEL - 2.5 g/25 mL Kit Carton

PRINCIPAL DISPLAY PANEL - 5 g/50 mL Vial Label

Immune Globulin Infusion 10% (Human)

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421
U.S. License No. 1898

Infuse 2nd

5 g/
50 mL

IG

LE-07-54409

Takeda

PRINCIPAL DISPLAY PANEL - 5 g/50 mL Vial Label

PRINCIPAL DISPLAY PANEL - 2.5 mL Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421

Infuse 1st

HY

2.5 mL
160 units per mL

Takeda

PRINCIPAL DISPLAY PANEL - 2.5 mL Vial Label

PRINCIPAL DISPLAY PANEL - 5 g/50 mL Kit Carton

Immune Globulin Infusion 10% (Human)

with Recombinant Human Hyaluronidase
HYQVIA

For Subcutaneous Administration Only.

Single-use dual vial unit

Directions for use:
Read the enclosed Package Insert.

No preservative

Rx Only

5 g/
50 mL

Takeda

PRINCIPAL DISPLAY PANEL - 5 g/50 mL Kit Carton

PRINCIPAL DISPLAY PANEL - 10 g/100 mL Vial Label

Immune Globulin Infusion 10% (Human)

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421
U.S. License No. 1898

Infuse 2nd

10 g/
100 mL

IG

LE-07-54412

Takeda

PRINCIPAL DISPLAY PANEL - 10 g/100 mL Vial Label

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421

Infuse 1st

5 mL
160 units per mL

HY

Takeda

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 g/100 mL Kit Carton

Immune Globulin Infusion 10% (Human)

with Recombinant Human Hyaluronidase
HYQVIA

For Subcutaneous Administration Only.

Single-use dual vial unit

Directions for use:
Read the enclosed Package Insert.

No preservative

Rx Only

10 g/
100 mL

Takeda

PRINCIPAL DISPLAY PANEL - 10 g/100 mL Kit Carton

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421

Infuse 1st

HY

10 mL
160 units per mL

LE-07-54417

Takeda

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 15 mL Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA

Single-Use Vial

Rx Only

Takeda Pharmaceuticals U.S.A., Inc.
Lexington, MA 02421

Infuse 1st

HY

15 mL
160 units per mL

LE-07-54420

Takeda

PRINCIPAL DISPLAY PANEL - 15 mL Vial Label
HYQVIA 
immune globulin infusion 10% (human) with recombinant human hyaluronidase kit
Product Information
Product TypePLASMA DERIVATIVEItem Code (Source)NDC:83703-038
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83703-038-021 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 VIAL, GLASS 25 mL
Part 21 VIAL, GLASS 1.25 mL
Part 1 of 2
IMMUNE GLOBULIN INFUSION (HUMAN), 10% 
human immuneglobulin g solution
Product Information
Item Code (Source)NDC:0944-2715
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS) HUMAN IMMUNOGLOBULIN G100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCINE (UNII: TE7660XO1C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2715-2525 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Part 2 of 2
RECOMBINANT HUMAN HYALURONIDASE 
hyaluronidase (human recombinant) solution
Product Information
Item Code (Source)NDC:0944-2720
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIDASE (HUMAN RECOMBINANT) (UNII: 743QUY4VD8) (HYALURONIDASE (HUMAN RECOMBINANT) - UNII:743QUY4VD8) HYALURONIDASE (HUMAN RECOMBINANT)160 [USP'U]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE (UNII: SE337SVY37)  
ALBUMIN HUMAN (UNII: ZIF514RVZR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2720-031.25 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
HYQVIA 
immune globulin infusion 10% (human) with recombinant human hyaluronidase kit
Product Information
Product TypePLASMA DERIVATIVEItem Code (Source)NDC:83703-039
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83703-039-021 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 VIAL, GLASS 50 mL
Part 21 VIAL, GLASS 2.5 mL
Part 1 of 2
IMMUNE GLOBULIN INFUSION (HUMAN), 10% 
human immuneglobulin g solution
Product Information
Item Code (Source)NDC:0944-2716
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS) HUMAN IMMUNOGLOBULIN G100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCINE (UNII: TE7660XO1C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2716-0550 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540206/04/2012
Part 2 of 2
RECOMBINANT HUMAN HYALURONIDASE 
hyaluronidase (human recombinant) solution
Product Information
Item Code (Source)NDC:0944-2721
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIDASE (HUMAN RECOMBINANT) (UNII: 743QUY4VD8) (HYALURONIDASE (HUMAN RECOMBINANT) - UNII:743QUY4VD8) HYALURONIDASE (HUMAN RECOMBINANT)160 [USP'U]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE (UNII: SE337SVY37)  
ALBUMIN HUMAN (UNII: ZIF514RVZR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2721-032.5 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
HYQVIA 
immune globulin infusion 10% (human) with recombinant human hyaluronidase kit
Product Information
Product TypePLASMA DERIVATIVEItem Code (Source)NDC:83703-040
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83703-040-021 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 VIAL, GLASS 100 mL
Part 21 VIAL, GLASS 5 mL
Part 1 of 2
IMMUNE GLOBULIN INFUSION (HUMAN), 10% 
human immuneglobulin g solution
Product Information
Item Code (Source)NDC:0944-2717
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS) HUMAN IMMUNOGLOBULIN G100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCINE (UNII: TE7660XO1C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2717-10100 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540206/04/2012
Part 2 of 2
RECOMBINANT HUMAN HYALURONIDASE 
hyaluronidase (human recombinant) solution
Product Information
Item Code (Source)NDC:0944-2722
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIDASE (HUMAN RECOMBINANT) (UNII: 743QUY4VD8) (HYALURONIDASE (HUMAN RECOMBINANT) - UNII:743QUY4VD8) HYALURONIDASE (HUMAN RECOMBINANT)160 [USP'U]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE (UNII: SE337SVY37)  
ALBUMIN HUMAN (UNII: ZIF514RVZR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2722-035 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
HYQVIA 
immune globulin infusion 10% (human) with recombinant human hyaluronidase kit
Product Information
Product TypePLASMA DERIVATIVEItem Code (Source)NDC:83703-041
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83703-041-021 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 VIAL, GLASS 200 mL
Part 21 VIAL, GLASS 10 mL
Part 1 of 2
IMMUNE GLOBULIN INFUSION (HUMAN), 10% 
human immuneglobulin g solution
Product Information
Item Code (Source)NDC:0944-2718
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS) HUMAN IMMUNOGLOBULIN G100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCINE (UNII: TE7660XO1C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2718-20200 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540206/04/2012
Part 2 of 2
RECOMBINANT HUMAN HYALURONIDASE 
hyaluronidase (human recombinant) solution
Product Information
Item Code (Source)NDC:0944-2723
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIDASE (HUMAN RECOMBINANT) (UNII: 743QUY4VD8) (HYALURONIDASE (HUMAN RECOMBINANT) - UNII:743QUY4VD8) HYALURONIDASE (HUMAN RECOMBINANT)160 [USP'U]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE (UNII: SE337SVY37)  
ALBUMIN HUMAN (UNII: ZIF514RVZR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2723-0310 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
HYQVIA 
immune globulin infusion 10% (human) with recombinant human hyaluronidase kit
Product Information
Product TypePLASMA DERIVATIVEItem Code (Source)NDC:83703-042
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83703-042-021 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 VIAL, GLASS 300 mL
Part 21 VIAL, GLASS 15 mL
Part 1 of 2
IMMUNE GLOBULIN INFUSION (HUMAN), 10% 
human immuneglobulin g solution
Product Information
Item Code (Source)NDC:0944-2719
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS) HUMAN IMMUNOGLOBULIN G100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCINE (UNII: TE7660XO1C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2719-30300 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540206/04/2012
Part 2 of 2
RECOMBINANT HUMAN HYALURONIDASE 
hyaluronidase (human recombinant) solution
Product Information
Item Code (Source)NDC:0944-2724
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIDASE (HUMAN RECOMBINANT) (UNII: 743QUY4VD8) (HYALURONIDASE (HUMAN RECOMBINANT) - UNII:743QUY4VD8) HYALURONIDASE (HUMAN RECOMBINANT)160 [USP'U]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE (UNII: SE337SVY37)  
ALBUMIN HUMAN (UNII: ZIF514RVZR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0944-2724-0315 mL in 1 VIAL, GLASS; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12540209/12/2014
Labeler - Bamboo US BidCo LLC (119087615)

Revised: 6/2024
Document Id: 1b18d1a2-3263-3e09-e063-6294a90adc8a
Set id: 1a52ca88-a13c-7c67-e063-6394a90a1f67
Version: 2
Effective Time: 20240617
 
Bamboo US BidCo LLC